On the REPROCELL blog
Latest
Modeling Fibrosis Progression Ex Vivo: Opportunities for Anti-Fibrotic Drug Screening
Explore the benefits of ex vivo human tissue models for fibrosis research and anti-fibrotic drug screening, offering a more accurate alternative to conventional preclinical methods.
15 January 2026
OpenCRISPR-1: The First AI-Designed CRISPR Editor for High-Precision Gene & Cell Therapy
Discover OpenCRISPR-1 — the first fully AI-designed CRISPR–Cas editor. Built by generative large language model, it enables high-efficiency, high-specificity genome and base editing in human cells. Ideal for cell therapy, stem-cell research, and advanced gene-editing workflows.
16 December 2025
Enhancing Experimental Precision with the Alvetex® Advanced Culture System
Discover how Alvetex® Advanced enhances experimental precision with its flexible and functional 3D culture system for creating biologically accurate human skin models.
04 December 2025
iPSC-, MSC- and iMSC-Derived Exosome Therapeutics: The Cell-Free Future of Regenerative Medicine
Explore the future of regenerative medicine with iPSC-, MSC-, and iMSC-derived exosome therapeutics, focusing on their advantages, challenges, and clinical potential.
19 November 2025